Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Author Response to “COVID-19 Outcomes Among Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-cell Recipients: Correspondence”

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.09.019Source: DataRank Database

Author Response to “COVID-19 Outcomes Among Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-cell Recipients: Correspondence” is a research paper published in Transplantation and Cellular Therapy (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: hybridTopics (21)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Catherine Liu ORCID,Emily A. Rosen ORCID

Live enrichment

PubMed:39321924 OpenAlex:https://openalex.org/W4402737806

National Institute of Allergy and Infectious Diseases

Grant: T32 AI118690

Pfizer

National Institutes of Health

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.jtct.2024.09.019

publisherhttps://doi.org/10.1016/j.jtct.2024.09.019

publisherhttps://api.elsevier.com/content/article/PII:S2666636724006870?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666636724006870?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39321924

Fields of Study

COVID-19 and healthcare impactsCAR-T cell therapy researchHematopoietic Stem Cell Transplantation

Keywords

Chimeric antigen receptorHematopoietic cellCoronavirus disease 2019 (COVID-19)Hematopoietic stem cell transplantationImmunologyVirologyAntigenHematopoietic stem cellHaematopoiesisCellMedicineT cellBiologyTransplantationStem cellImmune systemInternal medicineGenetics